Position in ZVRA
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$886,814
+$310,447 QoQ
Shares Held
61,842
0.0% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#68
of 158 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IFG Advisors, LLC holds $997,514 across 2 Biotechnology names. ZVRA ranks #1 (88.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
This page
|
61,842 | $886,814 | |
| 2 | REPL |
Replimune Group, Inc.
|
10,000 | $110,700 |
All Filings in ZVRA
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $886,814 | 61,842 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $576,367 | 61,842 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $260,288 | 29,050 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $276,265 | 29,050 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $255,930 | 29,050 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $217,584 | 29,050 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $242,277 | 29,050 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $183,216 | 26,400 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $91,630 | 18,700 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $108,460 | 18,700 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $84,495 | 12,900 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $62,178 | 12,900 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $71,655 | 14,050 | Shares | Sole | 2023-07-18 | |
| No filing history on record for this holder in this stock. | ||||||